InsiderDB

Lobbying disclosures · Lobbying report

NTRA: second_quarter 2026 lobbying report

Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.

Follow NTRA
Became public
Jul 10, 2026, 4:01 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 5:29 PM EST

Why this is connected

Exact legal-name match: Natera, Inc. (https://www.sec.gov/Archives/edgar/data/1604821/).

Reported lobbying amounts

Expenses: $150,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/fad9c929-0df4-4fd4-94db-cbeedfd5c34e/","filing_uuid":"fad9c929-0df4-4fd4-94db-cbeedfd5c34e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/fad9c929-0df4-4fd4-94db-cbeedfd5c34e/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Todd Trautner","dt_posted":"2026-07-10T16:01:40-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"130111 McCallen Pass","registrant_address_2":"Suite 100 Building A","registrant_different_address":false,"registrant_city":"Austin","registrant_state":"TX","registrant_zip":"78753","registrant":{"id":401109130,"url":"https://lda.gov/api/v1/registrants/401109130/","house_registrant_id":66831,"name":"NATERA INC","description":null,"address_1":"130111 McCallen Pass","address_2":"Suite 100 Building A","address_3":null,"address_4":null,"city":"Austin","state":"TX","state_display":"Texas","zip":"78753","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TODD TRAUTNER","contact_telephone":"+1 216-832-2620","dt_updated":"2026-07-28T19:18:18.321261-04:00"},"client":{"id":64075,"url":"https://lda.gov/api/v1/clients/64075/","client_id":64075,"name":"NATERA INC","general_description":"health care testing and diagnostics company","client_government_entity":null,"client_self_select":true,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148757,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"TRAUTNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+2.51% NTRA

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in NTRA

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.